Skip to main content

PATH and Walter Reed Army Institute of Research announce largest-ever controlled malaria infection study

This study in adult US volunteers will investigate which changes in the RTS,S malaria vaccine candidate regimen increase protection the most. Read more...

PATH partners with the Mahidol Oxford Tropical Medicine Research Unit on first study of the RTS,S malaria vaccine in Asia

Study is the first step toward understanding the vaccine’s potential role in elimination campaigns and combating drug resistance across Southeast Asia’s Greater Mekong Subregion. Read more...

PATH/Doune Porter

Test your knowledge to help end malaria

We’re asking you to put your knowledge to the test with a three-question quiz. Ready to begin?

Home

Latest

PATH and Walter Reed Army Institute of Research announce largest-ever controlled malaria infection study

PATH partners with the Mahidol Oxford Tropical Medicine Research Unit on first study of the RTS,S malaria vaccine in Asia

Return on innovation: Why global health R&D is a smart investment for the United States

Accelerating US Progress in Combating Malaria Worldwide: Recommendations for Maximizing Investments Toward a World Free From Malaria

Radboud University Medical Center, the Instituto de Medicina Molecular, and PATH’s Malaria Vaccine Initiative will collaborate on first-in-human study of a novel malaria vaccine approach

RTS,S Frequently Asked Questions (FAQs)

The PATH Malaria Vaccine Initiative

Preparing for malaria vaccines in Africa: A tool for malaria vaccine decision-making

RTS,S malaria vaccine candidate

Researching and addressing community perceptions of vaccines and malaria

PATH and GSK welcome progress toward RTS,S malaria vaccine pilot implementation with selection of countries

MVI Welcomes New Support from GHIT Fund for Development of Transmission-Blocking Vaccine

Twitter @MalariaVaccine

A clear case for investment in #globalhealth and R&D! #foreignaid (via @forbes) https://t.co/WWq63dRKEi

19 Sep 2017

“89 cents of every dollar the U.S. government invests in global health R&D stays within the United States.” https://t.co/bOlydLrT6n

18 Sep 2017

More evidence that #vaccineswork! @Gavi will save 20 million lives and $350B by 2020. https://t.co/zPw6iq8OqT https://t.co/aBiOqQCXlr

15 Sep 2017

Inspiring to see #globalhealth improvements made over time—and what’s possible in the future. #GoalKeepers17… https://t.co/nUSSlnEihe

14 Sep 2017

RT @Imperial_CICH: LAST CHANCE TO REGISTER! #Malaria - can we ever get rid of it? https://t.co/OHuHLomlmz #CICHSeminar https://t.co/PiPJQK2GTH

14 Sep 2017

RT @gatesfoundation: To see the progress we want by 2030, we're tracking 18 goals that are fundamental to people’s health and well-being… https://t.co/bcBqcOWXLV

13 Sep 2017

RT @HarvardMalaria: Charles Louis Alphonse Laveran discovered the malaria parasite — but faced an uphill battle convincing others https://t.co/mrlS6tJA4r

12 Sep 2017

RT @GHTCoalition: Nominate an R&D partnership/political champion of #globalhealth R&D for our first Innovating for Impact Awards!… https://t.co/pEEQvwoVkG

11 Sep 2017

We are excited to work with @wrair and GSK on the largest #malaria challenge trial ever conducted:… https://t.co/dDpZ7fHun7

8 Sep 2017

RT @HarvardMalaria: Scientists found boosting mothers' malaria immune response, as via vaccination, results in better infant protection https://t.co/X9aZf96ZGl

7 Sep 2017

Booster shot: Gates Foundation gives @PATHtweets $120 million for #vaccine work https://t.co/mZUZZ5iXu9 via @seattletimes

6 Sep 2017

In A Case That Is 'Almost Impossible,' Girl Dies Of #Malaria In Italy https://t.co/mmRg54BLEg

5 Sep 2017